Lineage, Inc. Common Stock (LINE)vsSeritage Growth Properties (SRG)
LINE
Lineage, Inc. Common Stock
$43.98
-1.32%
REAL ESTATE · Cap: $10.27B
SRG
Seritage Growth Properties
$2.63
-3.58%
REAL ESTATE · Cap: $149.82M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 34376% more annual revenue ($5.36B vs $15.55M). SRG leads profitability with a 0.0% profit margin vs -2.7%. LINE earns a higher WallStSmart Score of 36/100 (F).
LINE
Hold36
out of 100
Grade: F
SRG
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
-53.5%
Fair Value
$1.98
Current Price
$2.63
$0.65 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -25.9% — below average capital efficiency
Revenue declined 98.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : SRG
The strongest argument for SRG centers on Price/Book, Debt/Equity.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : SRG
The primary concerns for SRG are Market Cap, Profit Margin, Return on Equity.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while SRG is a value play — different risk/reward profiles.
LINE is growing revenue faster at 0.4% — sustainability is the question.
SRG generates stronger free cash flow (-6M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LINE scores higher overall (36/100 vs 24/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Seritage Growth Properties
REAL ESTATE · REAL ESTATE SERVICES · USA
Seritage Growth Properties is a publicly traded, self-managed and self-managed REIT with 166 wholly owned properties and 29 unconsolidated properties totaling approximately 30.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?